In two Phase 3 trials (SURMOUNT-OSA 1 & 2), tirzepatide (Mounjaro) a dual GIP/GLP-1 receptor agonist reduced the severity of obstructive sleep apnea (OSA) by up to 63% after 52 weeks
Yes, one of its primary mechanisms is delayed gastric emptying, which enhances feelings of fullness and reduces meal frequency
Book Your Consultation Treatment Details payments Pricing From: 25 verified_user Practitioner Charlotte Barratt location_on Location Beech House, 178b Ashford Rd, Bearsted, Maidstone ME14 4NB health_and_safety Safe, Medical Environment Patient Results
100% plant-based capsules for enhanced naturality To ensure safe and effective administration while preserving naturality, we use 100% plant-based capsules
A more mundane explanation is that hot water evaporates faster than cold, decreasing its volume and thus the time it takes to freeze